$CCCC Cashflow Statement | Understand Stock

$CCCC

$3.21 +$0.23 (7.72%) Close

$CCCC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows used in operating activities:
Net loss
Adjustments to reconcile net loss to cash used in operating activities:
Stock-based compensation expense
Impairment loss on right-of-use asset
Depreciation and amortization
Reduction in carrying amount of right-of-use asset
Accretion of premium on marketable securities
Amortization of debt discount—related party
Loss on early extinguishment of debt
Other
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current and long-term assets
Accounts payable
Accrued expenses and other current liabilities
Operating lease liability
Deferred revenue
Net cash used in operating activities
Cash flows provided by investing activities:
Proceeds from maturities of marketable securities
Purchase of marketable securities
Purchases of property and equipment
Net cash used in investing activities
Cash flows provided by financing activities:
Proceeds from follow-on offering, net of issuance costs paid of $11.3 million
Proceeds from issuance of common stock
Underwritten Offering
At-The-Market Equity Program
Betta Pharma Stock Purchase Agreement
Total proceeds from issuance of common stock
Payment of long-term debt − related party
Proceeds from exercises of stock options
Payment of initial public offering costs
Other
Net cash provided by financing activities

Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Less: restricted cash
Cash and cash equivalents at end of the year
Deferred revenue in accounts receivable
Cash paid for interest - related party
Cash paid for income taxes
Capital expenditures in accounts payable and accrued expenses
Operating lease liabilities arising from obtaining right-of-use assets

Comments